Cargando…
Dengue seroprevalence and force of primary infection in a representative population of urban dwelling Indonesian children
BACKGROUND: Indonesia reports the second highest dengue disease burden in the world; these data are from passive surveillance reports and are likely to be significant underestimates. Age-stratified seroprevalence data are relatively unbiased indicators of past exposure and allow understanding of tra...
Autores principales: | Prayitno, Ari, Taurel, Anne-Frieda, Nealon, Joshua, Satari, Hindra Irawan, Karyanti, Mulya Rahma, Sekartini, Rini, Soedjatmiko, Soedjatmiko, Gunardi, Hartono, Medise, Bernie Endyarni, Sasmono, R. Tedjo, Simmerman, James Mark, Bouckenooghe, Alain, Hadinegoro, Sri Rezeki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5472274/ https://www.ncbi.nlm.nih.gov/pubmed/28617803 http://dx.doi.org/10.1371/journal.pntd.0005621 |
Ejemplares similares
-
Correction: Dengue seroprevalence and force of primary infection in a representative population of urban dwelling Indonesian children
por: Prayitno, Ari, et al.
Publicado: (2018) -
A novel Vi-diphtheria toxoid typhoid conjugate vaccine is safe and can induce immunogenicity in healthy Indonesian children 2–11 years: a phase II preliminary report
por: Medise, Bernie Endyarni, et al.
Publicado: (2020) -
Six-month follow up of a randomized clinical trial-phase I study in Indonesian adults and children: Safety and immunogenicity of Salmonella typhi polysaccharide-diphtheria toxoid (Vi-DT) conjugate vaccine
por: Medise, Bernie Endyarni, et al.
Publicado: (2019) -
DTwP-HB-Hib: antibody persistence after a primary series, immune response and safety after a booster dose in children 18–24 months old
por: Gunardi, Hartono, et al.
Publicado: (2018) -
Diphtheria outbreak in Jakarta and Tangerang, Indonesia: Epidemiological and clinical predictor factors for death
por: Arguni, Eggi, et al.
Publicado: (2021)